RxGen Appoints Steve Gullans to Chairman and Matthew Lawrence to President and CSO Hamden, CT April 2, 2008 -- RxGen Inc. announces the promotion of Matthew Lawrence, Ph.D., M.D, to the position of President and Chief Scientific Officer. Dr. Lawrence will replace Steve Gullans, who had previously held the position of President and CEO and who ...
Therapeutic Development Through Innovative Research
Monthly Archives: April 2008
